Growth Metrics

Bristol Myers Squibb (BMYMP) Total Current Liabilities (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Total Current Liabilities for 17 consecutive years, with $23.4 billion as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities fell 1.5% to $23.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $23.4 billion through Dec 2025, down 1.5% year-over-year, with the annual reading at $23.4 billion for FY2025, 1.5% down from the prior year.
  • Total Current Liabilities for Q4 2025 was $23.4 billion at Bristol Myers Squibb, down from $28.1 billion in the prior quarter.
  • The five-year high for Total Current Liabilities was $28.1 billion in Q3 2025, with the low at $17.3 billion in Q1 2021.
  • Average Total Current Liabilities over 5 years is $22.4 billion, with a median of $22.5 billion recorded in 2023.
  • The sharpest move saw Total Current Liabilities decreased 18.91% in 2021, then skyrocketed 35.3% in 2024.
  • Over 5 years, Total Current Liabilities stood at $21.9 billion in 2021, then rose by 0.1% to $21.9 billion in 2022, then increased by 1.7% to $22.3 billion in 2023, then rose by 6.79% to $23.8 billion in 2024, then fell by 1.5% to $23.4 billion in 2025.
  • According to Business Quant data, Total Current Liabilities over the past three periods came in at $23.4 billion, $28.1 billion, and $27.5 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.